Dual Mobilization Enhances CD34+ Yield Across All Donor Types
August 1, 2022Dual Mobilization Enhances CD34+ Yield Across All Donor Types Mobilized peripheral blood has now surpassed bone marrow as the preferred source of CD34+ hematopoietic stem and progenitor cells (HSPCs) for […]
The Therapeutic Potential of HSC-based Gene Therapies
July 25, 2022The Therapeutic Potential of HSC-based Gene Therapies Hematopoietic stem cells (HSCs) have immense therapeutic potential because of their ability for both self-renewal and multi-lineage differentiation to maintain hematopoietic homeostasis. This […]
A Decade of Innovation: CAR-T Successes and Latest Developments
July 6, 2022A Decade of Innovation: CAR-T Successes and Latest Developments After a decade of innovation, chimeric antigen receptor (CAR)-T cell therapy remains at the forefront of the cell and gene therapy […]
Why You Should Start Clinical Grade Cell Supply Discussions Early in Cell and Gene Therapy Development
May 24, 2022Why You Should Start Clinical Grade Cell Supply Discussions Early in Cell and Gene Therapy Development Cell and gene therapies represent an expanding category of transformative medicines with the potential […]
What You Need to Know About Regenerative Medicine in 2022: Industry and Tech Trends
April 20, 2022What You Need to Know About Regenerative Medicine in 2022: Industry and Tech Trends Growth in the Regenerative Medicine Field The regenerative medicine sector is on track for another watershed […]
AllCells Opens a New Collection Facility in Houston, Texas
March 29, 2022AllCells Opens a New Collection Facility in Houston, Texas Expanding Its Donor Network AllCells, the leading provider of human hematological products and services, is pleased to announce the opening of […]
A Donor-Centric Approach to Cell and Gene Therapy
February 3, 2022In the past decade, emerging therapeutic modalities like cell and gene therapies have opened up new treatment options for previously intractable diseases, changing the industry needs for primary tissues. While […]
AllCells Announces First to Market Launch of In Stock GMP-Compliant Cryopreserved Leukopaks
January 28, 2022Collected from qualified healthy donors that meet baseline FDA 21 CFR 1271 requirements, industry’s first In Stock GMP-compliant Cryopreserved Leukopaks significantly decrease lead time AllCells, the industry leader in the […]
FAQ Series: The Science Behind Cryopreservation
January 11, 2022Primary cells, such as those isolated from the bone marrow or peripheral blood, are important for a wide scope of research and clinical applications – from studying molecular mechanisms driving disease progression, to […]
GMP-Compliant Leukopaks for Allogeneic Cell Therapies
December 13, 2021Adoptive cell therapies (ACTs), which is a treatment based on transferring cells (most often immune cells) into a patient, have revolutionized the standard of care to treat a broad range […]
